- Home
- NYC vs FLGC Comparison
NYC vs FLGC Comparison
Compare NYC & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- FLGC
- Stock Information
- Founded
- NYC 2013
- FLGC 2019
- Country
- NYC United States
- FLGC United States
- Employees
- NYC N/A
- FLGC N/A
- Industry
- NYC Real Estate
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- NYC Finance
- FLGC Health Care
- Exchange
- NYC Nasdaq
- FLGC Nasdaq
- Market Cap
- NYC 23.8M
- FLGC 26.5M
- IPO Year
- NYC N/A
- FLGC 2021
- Fundamental
- Price
- NYC $8.77
- FLGC $1.17
- Analyst Decision
- NYC
- FLGC Strong Buy
- Analyst Count
- NYC 0
- FLGC 3
- Target Price
- NYC N/A
- FLGC $6.50
- AVG Volume (30 Days)
- NYC 3.9K
- FLGC 533.2K
- Earning Date
- NYC 11-12-2024
- FLGC 11-13-2024
- Dividend Yield
- NYC N/A
- FLGC N/A
- EPS Growth
- NYC N/A
- FLGC N/A
- EPS
- NYC N/A
- FLGC N/A
- Revenue
- NYC $62,061,000.00
- FLGC $64,154,000.00
- Revenue This Year
- NYC N/A
- FLGC N/A
- Revenue Next Year
- NYC $3.18
- FLGC $19.90
- P/E Ratio
- NYC N/A
- FLGC N/A
- Revenue Growth
- NYC N/A
- FLGC N/A
- 52 Week Low
- NYC $5.46
- FLGC $0.70
- 52 Week High
- NYC $10.91
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- NYC 47.92
- FLGC 40.65
- Support Level
- NYC $8.54
- FLGC $1.11
- Resistance Level
- NYC $8.96
- FLGC $1.63
- Average True Range (ATR)
- NYC 0.31
- FLGC 0.18
- MACD
- NYC -0.01
- FLGC -0.05
- Stochastic Oscillator
- NYC 45.49
- FLGC 6.67
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.